Drug Patent Watch

DECEMBER 18, 2024

Protecting your intellectual property is paramount. Drug patent prosecution is a complex and critical process that can make or break the success of a new medication. As a business professional in the pharmaceutical industry, understanding and implementing effective strategies for drug patent prosecution can be the difference between market domination and missed opportunities.

Drugs 52

Drugs Marketing Development Manufacturing 52

Pharmaceutical Technology

DECEMBER 18, 2024

Abera and Orexo have entered a partnership to develop and test the powder formulations of the formers vaccine candidates.

Vaccination 165

Vaccination Vaccine Development 165

Bio Pharma Dive

DECEMBER 18, 2024

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen as likely buyout targets.

Licensing 162

Licensing Licensing Medicine Development 162

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 18, 2024

People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures and implants.

Clinical Trials 154

Clinical Trials Clinical Trials Drugs Trials 154

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

DECEMBER 18, 2024

New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.

Trials 147

Trials 147

Bio Pharma Dive

DECEMBER 18, 2024

“Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The company plans to use its new funds to get to “proof of concept” for its medicines.

Development 147

Development Medicine Drugs 147

Bio Pharma Dive

DECEMBER 18, 2024

The Bill & Melinda Gates Foundation will invest up to $50 million in Tessera’s in vivo sickle cell therapy. Elsewhere, Cara agreed to a reverse merger and J&J had a drug application rejected.

In-Vivo 130

In-Vivo Drugs 130

Pharmaceutical Technology

DECEMBER 18, 2024

A new report identifies data content management as the primary driver of growth in the pharmaceuticals market.

Marketing 147

Marketing 147

Rethinking Clinical Trials

DECEMBER 18, 2024

Speaker Gbenga Ogedegbe, MD, MPH, FACP Dr. Adolph & Margaret Berger Professor of Population Health NYU Grossman School of Medicine Director, Institute for Excellence in Health Equity (IEHE) NYU Langone Health Slides Keywords Hypertension; Racial Disparities; Case Management; Telemonitoring Key Points There are significant racial disparities when it comes to stroke outcomes in the U.S., with Black and Hispanic populations experiencing poorer outcomes than Caucasian

Nurses 100

Nurses Clinical Trials Clinical Trials Trials 100

Pharmaceutical Technology

DECEMBER 18, 2024

Gilead Sciences has entered a strategic partnership with Terray for the discovery and development of small-molecule therapies.

Development 147

Development 147

Advertisement

Clinical Supply

XTalks

DECEMBER 18, 2024

The US Food and Drug Administration (FDA) has granted approval to Checkpoint Therapeutics PD-L1 inhibitor Unloxcyt (cosibelimab-ipdl) for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) in patients who cannot be cured with surgery or radiation therapy. The approval marks the first product approval for the Massachusetts-based biotech and the first approved anti-programmed death-ligand 1 (PD-L1) treatment for advanced cSCC. cSCC is the second most common fo

FDA Approval 95

FDA Approval Antibody Immune Response Marketing 95

Pharmaceutical Technology

DECEMBER 18, 2024

Improper advertising on media constituted a large part of traffic directed to the companies websites.

Production 147

Production 147

Bio Pharma Dive

DECEMBER 18, 2024

Lawmakers on Tuesday released the text of a bipartisan agreement to fund the government through March. It could reshape the pharmacy supply chain by reforming how drug middlemen do business.

Pharmacy 100

Pharmacy Drugs 100

Pharmaceutical Technology

DECEMBER 18, 2024

Picking the right clinical partners will be critical for oncology innovators hoping to stay up to speed in a rapidly changing industry.

147

147

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

pharmaphorum

DECEMBER 18, 2024

The FDA has started a review of MSD's RSV antibody clesrovimab, a potential rival to Beyfortus, with a verdict due in the middle of next year

Antibody 89

Antibody 89

Pharmaceutical Technology

DECEMBER 18, 2024

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.

Insulin 147

Insulin Drugs 147

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 18, 2024

India needs new drugs, vaccines, and improve infection control practices to thwart antimicrobial resistance (AMR). From an India and global perspective, the recent advances in AMR treatment are bacteriophage therapy, nanotechnology, immunotherapies, among others. According to Dr Prabhu Vinayagam, medical advisor, Orchid AMS, a division of Orchid Pharma, the latest developments are novel antimicrobial agents.

Drugs 103

Drugs Vaccination Vaccine Development 103

pharmaphorum

DECEMBER 18, 2024

SiteOne Therapeutics has completed a $100 million third-round financing that will support clinical trials of its non-opioid painkiller.

Clinical Trials 75

Clinical Trials Clinical Trials Trials 75

Advertisement

Clinical Supply

XTalks

DECEMBER 18, 2024

Neurocrine Biosciences Crenessity (crinecerfont) has been given the green light by the US Food and Drug Administration (FDA) as a new treatment for congenital adrenal hyperplasia (CAH). The approval marks a significant step in addressing a condition that has historically relied on decades-old therapies. The therapy is approved to be used in combination with glucocorticoid replacement therapies (steroids) to control androgen levels in adults and pediatric patients four years of age and older with

Genetics 66

Genetics Hormones Trials Drugs 66

Fierce Pharma

DECEMBER 18, 2024

Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. | Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were catalogued in a recent edition of the FDA's weekly enforcement report.

Production 60

Production Drugs 60

pharmaphorum

DECEMBER 18, 2024

Sensorion's gene therapy for otoferlin-related hearing loss has shown early signs of improving hearing in two toddlers in a phase 1/2 trial.

Gene Therapy 59

Gene Therapy Gene Trials 59

Pharmaceutical Commerce

DECEMBER 18, 2024

Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses observations in enterprise value growth and enterprise value-to-sales ratios among top biopharmaceutical companies.

Sales 52

Sales Marketing 52

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

pharmaphorum

DECEMBER 18, 2024

Luigi Mangione has been charged with first-degree murder "in furtherance of terrorism" in connection with the death of the UnitedHealth CEO

59

59

Pharmaceutical Commerce

DECEMBER 18, 2024

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.

Marketing 52

Marketing 52

pharmaphorum

DECEMBER 18, 2024

Explore a new GLP-1 opportunity for pharmaceutical companies to support patients in overcoming emotional barriers to weight loss. Learn more about the potential benefits and strategies for addressing these challenges.

52

52

Pharmaceutical Commerce

DECEMBER 18, 2024

The latest news for pharma industry insiders.

52

52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

pharmaphorum

DECEMBER 18, 2024

Tune in to the podcast interview with Luca Quagliata from Thermo Fisher Scientific as he discusses the quantum leap in biomarkers and precision medicine in the age of Next-Generation Sequencing (NGS).

Medicine 52

Medicine 52

Imperical Blog

DECEMBER 18, 2024

Our blog team reviewed our 2024 clinical study blogs, and we selected these six worth re-reading. Check them out! 1. Sustainability in Business: Transparency and Keeping Score ESG: Environmental, social, and governance are factors that influence commercial success. Discover how Imperial achieved a sustainability rating… The post 6 Clinical Study Blogs Not to Miss appeared first on Imperial Clinical Research Services Blog.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

pharmaphorum

DECEMBER 18, 2024

Discover how clinical trials are evolving to prioritise patient needs and streamline processes for sites in 2025.

Clinical Trials 52

Clinical Trials Clinical Trials Trials 52

Fierce Pharma

DECEMBER 18, 2024

Looking to significantly bolster its presence across Asia, Indian solid dosage manufacturer ACG has kicked off operations at a massive plant in Thailand. | ACG this week commenced work at its new, 175,000-square-meter capsule production plant in Rayong on Thailands east coast. The sprawling facility, which is bigger than 32 football fields, represents the largest of its kind in the country and is expected to crank out some 20 billion hard gelatin capsules per year.

Manufacturing 56

Manufacturing Production 56

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials